Issue Date: August 24, 2009
Neglected Disease Consortium Formed
A team of scientists from industry, academia, and the nonprofit sector are collaborating to find new treatments for African sleeping sickness and leishmaniasis, two neglected tropical diseases that kill a total of 100,000 people each year. The consortium, which is starting out with $5 million to be distributed over the course of four years, includes IOTA Pharmaceuticals, Mercachem, Nycomed, the Drugs for Neglected Diseases Initiative, the . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society